arrow
E

Evan N. Cohen

Department of Translational Molecular Pathology
H指数:30
被引数:4,973

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temporal Dynamics of Bone Marrow Fibrocytes in the Progression of Primary Myelofibrosis

原发性骨髓纤维化进展过程中骨髓纤维细胞的时间动态

BLOOD
IF23.1
2024-11-050
PRE
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy

先前对化疗有反应的转移性HER2-negative乳腺癌患者的Pembrolizumab维持治疗

2024-04-170
PRE
Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy
2024-01-010
OAAI
Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy
2023-03-012
PRE
A Multi-center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System in support of FDA clearance
2023-03-010
PRE
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer
2022-12-1623
OAAI
Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development
2022-02-150
PRE
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression
2021-07-096
OAAI
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

CAR转导的自然杀伤细胞在CD19-Positive淋巴肿瘤中的应用

2020-02-061.4K
OAAI